Shares of French pharmaceutical group Sanofi fell sharply on Monday after the company flagged another delay to a US regulatory decision for its experimental multiple sclerosis drug tolebrutinib…

As investors stare down the start of 2026, one thing is clear: the playbook that worked over the last decade won’t cut it in the next.Between stubborn inflation…

India has moved to loosen long-standing restrictions in its nuclear power sector as it looks to speed up capacity additions and close widening funding gaps. Legal amendments introduced…